If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Good time for option exercise IMO. Share price near a low so minimising the gain on exercise, whilst avoiding any tax hike from an incoming Labour government.
Clearly a fairly junior employee though from the quantum, so not an insider.
The company is ONLY “very vulnerable to a bid” at whatever price Redmile/Vulpes would be happy to sell. Until at least one (but probably both) see a bid at a price that is attractive for them there will be no bid - because it is pointless to try.
Not rocket science 🙄
……..and another 1% for Brad. Now 16%+.
900,000 shares traded on Friday - biggest day for 5+ weeks - and yet thr company bout only 10k.
News coming?
Thanks, both.
tf, Certainly a bit busier at weekends, when the weekenders arrive, but I get the sense it is a shadow of what it was. Various Tripadvisor listed places no longer exist.
Hua Hin certainly greatly busier…..mostly with Russians trying to escape the draft, We like quiet though….just concerned how some places can keep going.
Tf….when you visited Pak Nam Pran, how busy was it?
Walked the length on the front tonight…..virtually no-one in any of the restaurants or hotels. We were the only ones where we ate. Same last night in different place. Max 8 tables in busiest place. And yet, around Pran Corner, there were around 40 food and drink stalls and about 700 people in small groups picnicking on the waterfront.
Is this a Covid-inspired cultural change that makes people avoid restaurants? Or is it just super-quiet?
Violindog,
It is completely pointless to debate price when everyone is looking at a different timeframe. And it is also pointless because no bidder currently appears to be in sight. The one thing that I expect everyone can agree on is that if a bidder emerges then the share price would instantly gap materially higher (which is effectively the point I made).
And, as data emerges, one would expect the valuation gap to close materially over the coming months.
Just on the question of any deal price for the whole company, it is totally pointless to debate it, as one or two have observed. When I said 6x the current share price, that would IMO be the level at which a bidder TOMORROW wouldn’t immediately be told to bugger off. I do not expect a deal tomorrow, nor one at 66p of so. But I do expect a deal at a higher price sometime before the end of 2025.
The point of mentioning 6x and the prior “derisory” comment is that I think the current market valuation is absolutely miles out - and I would expect to see material gains in the next few months to start to bridge that valuation gap.
They are required to notify. But have not been doing so.
Nothing the company can do about that, as they can only RNS notifications they have received.
This is not uncommon with non-UK shareholders, unfortunately.
Re RENX and potential premiums, we can readily work out what would happen if someone wanted to take Scancell out…..
There would be a process of price discovery via discussions with Redmile and Vulpes…..because there is little point in bidding if they wouldn’t sell. We know (from the note published a year ago) that Vulpes considered the share price “derisory” - and since then the share price has fallen despite having more promising fundamental news on trials etc.
My best guess is that any buyer would have to pay at least 6x the current share price to get support from Vulpes and Redmile……and that would still be a modest deal ticket price for the sector.